
SCM Valuation
Stellus Capital Investment Corp
- Overview
- Forecast
- Valuation
- Earnings
SCM Relative Valuation
SCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SCM is overvalued; if below, it's undervalued.
Historical Valuation
Stellus Capital Investment Corp (SCM) is now in the Fair zone, suggesting that its current forward PE ratio of 8.65 is considered Fairly compared with the five-year average of 8.92. The fair price of Stellus Capital Investment Corp (SCM) is between 13.63 to 18.00 according to relative valuation methord.
Relative Value
Fair Zone
13.63-18.00
Current Price:14.94
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.11
P/B
Median3y
1.01
Median5y
0.95
4.54
FCF Yield
Median3y
-4.34
Median5y
-14.18
Competitors Valuation Multiple
The average P/S ratio for SCM's competitors is 3.53, providing a benchmark for relative valuation. Stellus Capital Investment Corp Corp (SCM) exhibits a P/S ratio of 3.80, which is 7.70% above the industry average. Given its robust revenue growth of -30.28%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap

SCM.N
Stellus Capital Investment Corp
3.80
Average P/S: 3.53
-30.28%
423.12M

PSBD.N
Palmer Square Capital BDC Inc
Loss
-76.03%
454.52M

PNNT.N
Pennantpark Investment Corp
3.25
-24.12%
473.40M

GAIN.O
Gladstone Investment Corp
5.70
-4.16%
515.05M

CION.N
Cion Investment Corp
2.39
-112.41%
528.02M

TPVG.N
Triplepoint Venture Growth BDC Corp
2.50
12.32%
288.07M
People Also Watch

OABI
OmniAb Inc
2.060
USD
+4.04%

ALLO
Allogene Therapeutics Inc
1.360
USD
+3.03%

CRNT
Ceragon Networks Ltd
2.255
USD
+0.67%

BRY
Berry Corporation (Bry)
3.075
USD
-0.81%

RVNC
Revance Therapeutics Inc
3.650
USD
0.00%

ETON
Eton Pharmaceuticals Inc
14.520
USD
+0.83%

BWAY
Brainsway Ltd
12.090
USD
0.00%

OLMA
Olema Pharmaceuticals Inc
4.610
USD
+0.44%

OOMA
Ooma Inc
12.290
USD
+0.66%

SENEA
Seneca Foods Corp
103.950
USD
+0.41%
FAQ

Is Stellus Capital Investment Corp (SCM) currently overvalued or undervalued?
Stellus Capital Investment Corp (SCM) is now in the Fair zone, suggesting that its current forward PE ratio of 8.65 is considered Fairly compared with the five-year average of 8.92. The fair price of Stellus Capital Investment Corp (SCM) is between 13.63 to 18.00 according to relative valuation methord.

What is Stellus Capital Investment Corp (SCM) fair value?

How does SCM's valuation metrics compare to the industry average?

What is the current P/B ratio for Stellus Capital Investment Corp (SCM) as of Jul 22 2025?

What is the current FCF Yield for Stellus Capital Investment Corp (SCM) as of Jul 22 2025?

What is the current Forward P/E ratio for Stellus Capital Investment Corp (SCM) as of Jul 22 2025?
